UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1999-2006

2023

Volltextzugriff (PDF)

Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

Medicina (Kaunas, Lithuania), 2023-03, Vol.59 (3), p.557

2023

Volltextzugriff (PDF)

The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker

Tumor biology, 2016-09, Vol.37 (9), p.11903-11907

2016

Volltextzugriff (PDF)

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

Future oncology (London, England), 2022-03, Vol.18 (10), p.1235-1244

2022

Volltextzugriff (PDF)

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2369-2379

2020

Volltextzugriff (PDF)

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Indian journal of cancer, 2021-10, Vol.58 (4), p.561-566

2021

Volltextzugriff (PDF)

Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors

World journal of surgical oncology, 2012-02, Vol.10 (1), p.39-39, Article 39

2012

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-11, Vol.379 (21), p.2040-2051

2018

Volltextzugriff (PDF)

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Journal of oncology pharmacy practice, 2021-10, Vol.27 (7), p.1623-1630

2021

Volltextzugriff (PDF)

Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

The Turkish journal of gastroenterology, 2018-05, Vol.29 (3), p.259-269

2018

Volltextzugriff (PDF)

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Clinical colorectal cancer, 2017-03, Vol.16 (1), p.78-83

2017

Volltextzugriff (PDF)

Outcome of non-metastatic male breast cancer: 118 patients

Medical oncology (Northwood, London, England), 2012-06, Vol.29 (2), p.554-560

2012

Volltextzugriff (PDF)

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Medical oncology (Northwood, London, England), 2010-03, Vol.27 (1), p.29-33

2010

Volltextzugriff (PDF)

The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy

The Journal of surgical research, 2013-03, Vol.180 (1), p.e1-e9

2013

Volltextzugriff (PDF)

Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study

Current medical research and opinion, 2012-03, Vol.28 (3), p.401-413

2012

Volltextzugriff (PDF)

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology

Asian Pacific journal of cancer prevention : APJCP, 2013-01, Vol.14 (12), p.7367-7369

2013

Volltextzugriff (PDF)

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1547-1557

2020

Volltextzugriff (PDF)

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867

2021

Volltextzugriff (PDF)

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2023-06, Vol.401 (10391), p.1853-1865

2023

Volltextzugriff (PDF)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1015-1026

2017

Volltextzugriff (PDF)

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

BMC cancer, 2004-06, Vol.4 (1), p.29-29, Article 29

2004

Volltextzugriff (PDF)

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (12), p.1223

2022

Volltextzugriff (PDF)

The utility of serum tumor markers CEA and CA 15–3 for breast cancer prognosis and their association with clinicopathological parameters

Cancer treatment and research communications, 2021, Vol.28, p.100402-100402, Article 100402

2021

Volltextzugriff (PDF)

Retrospective evaluation of premenopausal hormone‐sensitive breast cancer patients treated with adjuvant gonadotropin‐releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Asia-Pacific journal of clinical oncology, 2018-04, Vol.14 (2), p.e145-e151

2018

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(154)

Sprache

Englisch
(154)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(138)
Science & Technology
(138)
Female
(131)
Middle Aged
(116)
Oncology
(102)
Male
(101)
Adult
(96)
Aged
(94)
Retrospective Studies
(61)
Aged, 80 And Over
(48)
Prognosis
(47)
Neoplasm Staging
(41)
Chemotherapy
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Medicine
(29)
Medicine & Public Health
(29)
Survival Rate
(26)
Treatment Outcome
(26)
Follow-Up Studies
(25)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker

Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Outcome of non-metastatic male breast cancer: 118 patients

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy

Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

The utility of serum tumor markers CEA and CA 15–3 for breast cancer prognosis and their association with clinicopathological parameters

Retrospective evaluation of premenopausal hormone‐sensitive breast cancer patients treated with adjuvant gonadotropin‐releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Aktive Filter

Suchergebnisse filtern